Cited by 85Pancreatic function and diabetesNeuroendocrine Tumor Research AdvancesPancreatic and Hepatic Oncology Research

Hyperinsulinemic hypoglycemia with nesidioblastosis: histologic features and growth factor expression

Open access
Rumilla, Kandelaria M, Erickson, Lori A, Service, F John, Vella, Adrian, Thompson, Geoffrey B, Grant, Clive S, Lloyd, Ricardo V·2009·Modern Pathology

Abstract

Hypoglycemia secondary to nesidioblastosis is rare in adults, and the pathogenesis of this condition is unknown. To determine factors leading to nesidioblastosis in adults, we analyzed 36 cases of nesidioblastosis including 27 cases of postgastric bypass nesidioblastosis and 9 cases of idiopathic nesidioblastosis in adults by immunohistochemistry using antibodies to insulin-like growth factor 1, insulin-like growth factor 2 (IGF2), insulin-like growth factor one receptor-alpha epidermal growth factor receptor, transforming growth factor-beta1 and 2, and transforming growth factor-beta receptor type 3. Fifty-two surgically excised pancreatic specimens from patients with benign exocrine tumors and no evidence of hypoglycemia were used as controls. There was increased IGF2, insulin-like growth factor receptor 1 receptor-alpha and transforming growth factor-beta receptor 3 expression in islets from nesidioblastosis patients compared to controls. Peliosis-type vascular ectasia was more common in nesidioblastosis patients compared to controls. These findings suggest that increased production of growth factors and growth factor receptors may contribute to the development of nesidioblastosis in adults.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/modpathol.2008.169

Cites

0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Pancreatic resection, the most commonly reported procedure, was performed in approximately 67% of patients.

    “Pancreatic resection, the most commonly reported procedure, was performed in approximately 67% of patients (66,103,105,107,114,116-123).”

    From Dumping syndrome after esophageal, gastric or bariatric surgery: Pathophysiology, diagnosis, and management (2017) · cites this paper as [119]

    The Tissue section (page unavailable) reports that all 36 selected patients with nesidioblastosis underwent partial pancreatectomy, so the paper documents pancreatic resection. It does not report that resection was the most commonly performed procedure or that approximately 67% of patients underwent it; the surgical history was a selection criterion for this cohort. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 41

  1. Steinbrook R. Surgery for severe obesity. N Engl J Med 2004;350:1075-1079.
  2. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002;288:1723-1727.
  3. Service GJ, Thompson GB, Service FJ, et al. Hyper- insulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med 2005;353: 249-254.
  4. Patti ME, McMahon G, Mun EC, et al. Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. (see com- ment). Diabetologia 2005;48:2236-2240.
  5. Eden Engstrom B, Burman P, Holdstock C, et al. Effects of gastric bypass on the GH/IGF-I axis in severe obesity-and a comparison with GH deficiency. Eur J of Endocrinol 2006;154:53-59.
  6. Carpenter T, Trautmann ME, Baron AD. Hyperinsuli- nemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med 2005;353: 2192-2194.
  7. Brown RE, Young RB. A possible role for the exocrine pancreas in the pathogenesis of neonatal leucine- sensitive hypoglycemia. Am J of Dig Dis 1970;15: 65-72.
  8. Yakovac WC, Baker L, Hummeler K. Beta cell nesidio- blastosis in idiopathic hypoglycemia of infancy. J Pediatr 1971;79:226-231.
  9. Aynsley-Green A, Polak JM, Bloom SR, et al. Nesidio- blastosis of the pancreas: definition of the syndrome and the management of the severe neonatal hyperin- sulinaemic hypoglycaemia. Arch Dis Child 1981;56: 496-508.
  10. Fournet JC, Verkarre V, De Lonlay P, et al. Loss of imprinted genes and paternal SUR1 mutations lead to hyperinsulinism in focal adenomatous hyperplasia. Ann Endocrinol 1998;59:485-491.
  11. Greer RM, Shah J, Jeske YW, et al. Genotype- phenotype associations in patients with severe hyper- insulinism of infancy. Pediatr Dev Pathol 2007;10: 25-34.
  12. Reinecke-Luthge A, Koschoreck F, Kloppel G. The molecular basis of persistent hyperinsulinemic hypo- glycemia of infancy and its pathologic substrates. Virchows Arch 2000;436:1-5.
  13. Fukuzawa R, Umezawa A, Morikawa Y, et al. Nesidio- blastosis and mixed hamartoma of the liver in Beck- with-Wiedemann syndrome: case study including analysis of H19 methylation and insulin-like growth factor 2 genotyping and imprinting. Pediatr Dev Pathol 2001;4:381-390.
  14. Kaczirek K, Niederle B. Nesidioblastosis: an old term and a new understanding. World J Surg 2004;28:1227- 1230.
  15. Service FJ, Natt N, Thompson GB, et al. Noninsulino- ma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults indepen- dent of mutations in Kir6.2 and SUR1 genes (see comment). J Clin Endocrinol Metab 1999; 84:1582-1589.
  16. Glaser B, Kesavan P, Heyman M, et al. Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med 1998;338:226-230.
  17. Lloyd R, Erickson L, Nascimento A, Kloppel G. Neoplasms causing nonhyperinsulinemic hypoglyce- mia. Endocr Pathol 1999;10:291-297.
  18. Beckers MM, Slee PH, van Doorn J. Hypoglycaemia in a patient with a gastrointestinal stromal tumour. Clin Endocrinol 2003;59:402-404.
  19. Berman J, Harland S. Hypoglycaemia caused by secretion of insulin-like growth factor 2 in a primary renal cell carcinoma. Clin Oncol (R Coll Radiol) 2001;13:367-369.
  20. Bujanda DA, Vera JC, Suarez MA, et al. Hypoglycemic coma secondary to big insulin-like growth factor II secretion by a giant phyllodes tumor of the breast. Breast J 2007;13:189-191.
  21. Daughaday WH. Hypoglycemia due to paraneoplastic secretion of insulin-like growth factor-I. J Clin En- docrinol Metab 2007;92:1616.
  22. de Boer J, Jager PL, Wiggers T, et al. The therapeutic challenge of a nonresectable solitary fibrous tumor in a hypoglycemic patient. Int J Clin Oncol 2006;11:478-481.
  23. Fernando HS, Hawkyard SJ, Poon P, Musa M. Renal cell carcinoma with non-islet cell tumor hypoglyce- mia. Int J Urol 2006;13:985-986.
  24. Kameyama K, Okumura N, Kokado Y, et al. Solitary fibrous tumor associated with non-islet cell tumor hypoglycemia. Ann Thorac Surg 2007;84:292-294.
  25. Sato R, Tsujino M, Nishida K, et al. High molecular weight form insulin-like growth factor II-producing mesenteric sarcoma causing hypoglycemia. Intern Med 2004;43:967-971.
  26. Wakami K, Tateyama H, Kawashima H, et al. Solitary fibrous tumor of the uterus producing high-molecular- weight insulin-like growth factor II and associated with hypoglycemia. Int J Gynecol Pathol 2005;24: 79-84.
  27. Fournet JC, Mayaud C, de Lonlay P, et al. Unbalanced expression of 11p15 imprinted genes in focal forms of congenital hyperinsulinism: association with a reduc- tion to homozygosity of a mutation in ABCC8 or KCNJ11. Am J Pathol 2001;158:2177-2184.
  28. de Lonlay P, Fournet J-C, Rahier J, et al. Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. J Clin Invest 1997; 100:802-807.
  29. Best LG, Gilbert-Barness E, Gerrard DE, Gendron- Fitzpatrick A, Opitz JM. 'Double-muscle' trait in cattle: a possible model for Wiedemann-Beckwith syndrome. Fetal Pediat Pathol 2006;25:9-20.
  30. Silha JV, Murphy LJ. Insights from insulin-like growth factor binding protein transgenic mice. Endocrinology 2002;143:3711-3714.
  31. Fontanie ´r S, Tost J, Wierinckx A, et al. Gene expression profiling in insulinomas of Men1 beta-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic beta-cell tumorigenesis. Endocr Relat Cancer 2006;13:1223-1236.
  32. Daughaday WH, Deuel TF. Tumor secretion of growth factors. Endocrinol Metab Clin North Am 1991;20:539-563.
  33. Kovacs K, Horvath E, Asa SL, et al. Microscopic peliosis of pancreatic islets in a woman with MEN-1 syndrome. Arch Pathol Lab Med 1986;110:607-610.
  34. Chetty R, Kennedy M, Ezzat S, Asa SL. Pancreatic endocrine pathology in von Hippel-Lindau disease: an expanding spectrum of lesions. Endocr Pathol 2004;15:141-148.
  35. Pernicone PJ, Lie JT. Isolated peliosis of pancreatic islet cell adenoma. Arch Pathol Lab Med 1987;111: 690-691.
  36. Carvajal SH, Mulvihill SJ. Postgastrectomy syndromes: dumping and diarrhea. Gastroenterol Clin North Am 1994;23:261-279.
  37. Joseph F, Younis N, Haydon G, et al. Peliosis of the spleen with massive recurrent hemorrhagic ascites, despite splenectomy, and associated with elevated levels of vascular endothelial growth factor. Eur J Gastroenterol Hepatol 2004;16:140-146. Review.
  38. Imhof A, Schneemann M, Schaffner A, Brandle M. Reactive hypoglycemia due to late dumping syndrome: successful treatment with acarbose. Swiss Med Wkly 2001;131:81-83.
  39. Abell TL, Minocha A. Gastrointestinal complications of bariatric surgery: diagnosis and therapy. Am J Med Sci 2006;331:214-218.
  40. Livingston EHMD, Huerta SMD, Arthur DRNMHA, et al. Male gender is a predictor of morbidity and age a predictor of mortality for patients undergoing gastric bypass surgery. Ann Surg 2002;236:576-582.
  41. Tymitz K, Kerlakian G, Engel A, Bollmer C. Gender differences in early outcomes following hand-assisted laparoscopic Roux-en-Y gastric bypass surgery: gender differences in bariatric surgery. Obes Surg 2007; 17:1588-1591.

Cited by

Sorted by citations

Authors
Rumilla, K. M., Erickson, L. A., Service, F. J., Vella, A., Thompson, G. B., Grant, C. S., & Lloyd, R. V.
Affiliations
Mayo Clinic (US)
Corresponding author
Lloyd, Ricardo V
Venue
Modern Pathology
Publisher
Elsevier BV
Published
2009-02
Volume
22
Issue
2
Pages
239-245
ISSN
0893-3952 (ISSN-L)
OpenAlex
W1986323441
Cited by
85
References
0
Citations by year
2026: 2 · 2025: 1 · 2024: 2 · 2023: 9 · 2022: 4 · 2021: 3 · 2020: 4 · 2019: 4 · 2017: 2 · 2016: 12 · 2015: 12 · 2014: 8 · 2013: 4 · 2012: 7
FWCI
3.87
Type
journal article
Language
en
Open access
Locations
  • Modern Pathology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Health Sciences › Medicine › Epidemiology › Neuroendocrine Tumor Research Advances
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
Keywords
nesidioblastosis, hyperinsulinemic hypoglycemia, insulin-like growth factor II, insulin-like growth factor I, IGF-1 receptor, epidermal growth factor receptor, TGF-β1, pancreatic islets, peliosis, angiodysplasia, growth factor expression
MeSH terms
Adult, Blood Vessels, Female, Humans, Hyperinsulinism, Hypoglycemia, Immunohistochemistry, Insulin-Like Growth Factor I, Insulin-Like Growth Factor II, Islets of Langerhans, Male, Middle Aged, Proteoglycans, Risk Factors, Gastric Bypass, Case-Control Studies, In Situ Hybridization, Receptor, IGF Type 1, Receptors, Transforming Growth Factor beta, Intercellular Signaling Peptides and Proteins, Nesidioblastosis, Transforming Growth Factor beta1, Transforming Growth Factor beta2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review